AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors

Author： Engel Joerg   Emons Guenter   Pinski Jacek   Schally Andrew V  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.6, 2012-06, pp. : 891-899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 488-494

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of LHRH-PE40 on target cells via LHRH receptors

By Deng Xin   Klussmann Sven   Wu Guang-Mou   Akkerman Doreen   Zhu Ya-Qin   Liu Ying   Chen Hang   Zhu Ping   Yu Bing-Zhi   Zhang Guo-Li  

Journal of Drug Targeting, Vol. 16, Iss. 5, 2008-06 ,pp. : 379-388

Informa Healthcare

Access to resources Recommend Favorite

LHRH-Targeted Drug Delivery Systems for Cancer Therapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 258-267

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticulate delivery of LHRH analogue for the treatment of prostate cancer

By Tomar Priti  

Pharmaceutical Development and Technology, Vol. 18, Iss. 3, 2013-06 ,pp. : 645-652

Informa Healthcare

Access to resources Recommend Favorite

Lhrh Receptors and Lhrh Receptor-Bearing Cells in Pituitaries of Streptozocin Diabetic Male Rats

By Bestetti G.E.   Barone D.   Walz A.   Moser B.   Boujon C.E.   Brandli-Baiocco A.   Rossi G.L.  

Pharmacological Research, Vol. 35, Iss. 4, 1997-04 ,pp. : 321-327

Academic Press

Access to resources Recommend Favorite